Effects of catalpalactone on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells

Environmental Toxicology and Pharmacology

Volumn 26, Issue 1, 2008, Pages 86-91

  Huang, Hai Shan ^a   Han, Xiang Hua ^a   Hwang, Bang Yeon ^a   Park, Jae In ^a   Yoo, Se Kuel ^b   Lee, Hak Ju ^b   Lim, Sung Cil ^a   Lee, Myung Koo ^a  

^a Chungbuk National University   (South Korea)

^b Korea Forest Research Institute   (South Korea)

Author keywords

Catalpalactone; Dopamine biosynthesis; L DOPA induced cytotoxicity; PC12 cells; Tyrosine hydroxylase

Indexed keywords

ACETYLCYSTEINE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CATALPA OVATA EXTRACT; CATALPALACTONE; CYCLIC AMP; DOPAMINE; LEVODOPA; PLANT EXTRACT; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CATALPA OVATA; CELL STRAIN; CELL VIABILITY; CYTOTOXICITY; DRUG EFFICACY; DRUG INHIBITION; IC 50; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

EID: 42049108623     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2008.02.005     Document Type: Article

References (36)

1. Abul-Hajj Y.J. Estrogen 1,2-epoxides or estrogen quinones/semiquinones. Biochem. Biophys. Res. Comm. 133 (1985) 1078-1085
2. An S.J., Pae H.O., Oh G.S., Choi B.M., Jeong S., Jang S.I., Oh H., Kwon T.O., Song C.E., and Chung H.T. Inhibition of TNF-alpha, IL-1beta, and IL-6 productions and NF-kappa B activation in lipopolysaccharide-activated RAW 264.7 macrophages by catalposide, an iridoid glycoside isolated from Catalpa ovata G. Don (Bignoniaceae). Int. Immunopharmacol. 2 (2002) 1173-1181
3. Basma A.N., Morris E.J., Nicklas W.J., and Geller H.M. L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem. 64 (1995) 825-832
4. Bolton J.L., Trush M.A., Penning T.M., Dryhurst G., and Monks T.J. Role of quinones in toxicology. Chem. Res. Toxicol. 13 (2000) 135-160
5. Young E.A., Duchemin A.-M., Neff N.H., and Hadjiconstantinou M. Parallel modulation of striatal dopamine synthetic enzymes by second messenger pathways. Eur. J. Pharmacol. 357 (1998) 15-23
6. Flowers-Geary L., Bleczinki W., Harvey R.G., and Penning T.M. Cytotoxicity and mutagenicity of polycyclic aromatic hydrocarbon ortho-quinones produced by dihydrodiol dehydrogenase. Chem. Biol. Interact. 99 (1996) 55-72
7. Graumann R., Paris I., Martinez-Alvarado P., Rumanque P., Perez-Pastene C., Cardenas S.P., Marin P., Diaz-Grez F., Caviedes R., Caviedes P., and Segura-Aguilar J. Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase. Pol. J. Pharmacol. 54 (2002) 573-579
8. Greene L.A., and Rein G. Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells. Brain Res. 129 (1977) 247-263
9. Inoue H., Okuda T., Hirata Y., Nagakura N., and Yoshizaki M. Structure of catalpalactone, a new phthalide from Catalpa wood. Chem. Pharm. Bull. 15 (1967) 786-792
10. Inoue H., Ueda S., Inoue K., and Shiobara Y. (2R)-Catalponone, a biosynthetic intermediate for prenylnaphthoquinone congeners of the wood of Catalpa ovata. Phytochem. 7 (1981) 1707-1710
11. Kapadia G.J., Sharma S.C., Tokuda H., Nishino H., and Ueda S. Inhibitory effect of iridoids on Epstein-Barr virus activation by a short-term in vitro assay for anti-tumor promoters. Cancer Lett. 102 (1996) 223-226
12. Kim K.S., Park D.H., Wessel T.C., Song B., Wagner J.A., and Joh T.H. A dual role for the cAMP-dependent protein kinase in tyrosine hydroxylase gene expression. Proc. Natl. Acad. Sci. USA 90 (1993) 3471-3475
13. Kim S.H., Shin J.S., Lee J.J., Yin S.Y., Kai M., and Lee M.K. Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells. Planta Med. 67 (2001) 609-613
14. Lee M.K., and Zhang Y.H. Inhibition of tyrosine hydroxylase by berberine. Med. Sci. Res. 24 (1996) 561-562
15. Lee M., Nohta H., and Ohkura Y. Occurrence of aromatic l-amino acid decarboxylase in human plasma and its assay by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 378 (1986) 329-336
16. Lee M.K., Zhang Y.H., Shin J.S., and Lee S.S. Inhibition of tyrosine hydroxylase by hydrastine. Med. Sci. Res. 25 (1997) 619-620
17. Lee J.J., Kim Y.M., Yin S.Y., Park H.D., Kang M.H., Hong J.T., and Lee M.K. Aggravation of L-DOPA-induced neurotoxicity by tetrahydropapaveroline in PC12 cells. Biochem. Pharmacol. 66 (2003) 1787-1795
18. Lowry O.H., Rosenbrough N.L., Farr A.L., and Randall R.L. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
19. Marsden C.D. Parkinson's disease. J. Neurosurg. Psychiatry 57 (1994) 672-681
20. McNaught K.S., Thull U., Carrupt P.A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P., and Marsden C.D. Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci. Lett. 206 (1996) 37-40
21. Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods 65 (1983) 55-63
22. Nagatsu T., Levitt M., and Udenfriend S. Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J. Biol. Chem. 239 (1964) 2910-2917
23. Nagatsu T., Oka K., and Kato K. Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J. Chromatogr. 163 (1979) 247-252
24. O'Brien P.J. Molecular mechanisms of quinone cytotoxicity. Chem. Biol. Interact. 80 (1991) 1-41
25. Oh H., Pae H.O., Oh G.S., Lee S.Y., Chai K.Y., Song C.E., Kwon T.O., Chung H.T., and Lee H.S. Inhibition of inducible nitric oxide synthesis by catalposide from Catalpa ovata. Planta Med. 68 (2002) 685-689
26. Rogers C.G., Boyes B.G., Matula T.I., Neville G., and Stapley R. Cytotoxic and genotoxic properties of tert-butyl-p-quinone (TBQ) in an in vitro assay system with Chinese hamster V79 cells and in strain D7 of Saccharomyces cerevisiae. Mutat. Res. 299 (1993) 9-18
27. Shafer T.J., and Atchison W.D. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicol. 12 (1991) 473-492
28. Shin J.S., Kim K.T., and Lee M.K. Inhibitiory effects of bulbocapnine on dopamine biosynthesis in PC12 cells. Neurosci. Lett. 244 (1998) 161-164
29. Shin J.S., Yun-Choi H.S., Kim E.I., and Lee M.K. Inhibitory effects of higenamine on dopamine content in PC12 cells. Planta Med. 65 (1999) 452-455
30. Shin J.S., Kim E.I., Kai M., and Lee M.K. Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res. 25 (2000) 363-368
31. Storch A., Ott S., Hwang Y.I., Ortmann R., Hein A., Frenzel S., Matsubara K., Ohta S., Wolf H.U., and Schwarz J. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter. Biochem. Pharmacol. 63 (2002) 909-920
32. Suzuki Y. Diuretic action of the fruit of Catalpa ovata G. DON. Nippon Yakurigaku Zasshi 64 (1968) 93-107
33. Tischler A.S., Perlman R.L., Morse G.M., and Sheard B.E. Glucocorticoids increase catecholamine synthesis and storage in PC12 cells pheochromocytoma cell culture. J. Nerurochrm. 40 (1983) 364-370
34. Yin S.Y., Kim Y.M., Lee J.J., Jin C.M., Yang Y.J., Ma J.J., Kang M.H., Kai M., and Lee M.K. Enantio-selective inhibition of (1R,9S)- and (1S,9R)-β-hydrastines on dopamine biosynthesis in PC12 cells. Neuropharmacol. 47 (2004) 1045-1052
35. Yin S.Y., Lee J.J., Kim Y.M., Jin C.M., Yang Y.J., Kang M.H., Kai M., and Lee M.K. Effects of (1R,9S)-β-hydrastine on L-DOPA-induced cytotoxicity in PC12 cells. Eur. J. Pharmacol. 488 (2004) 71-77
36. Ziv I., Zilkha-Falb R., Offen D., Shirvan A., Barzilai A., and Melamed E. Levodopa induces apoptosis in cultured neuronal cells: a possible accelerator of nigrostriatal degeneration in Parkinson's disease?. Mov. Disord. 12 (1997) 17-23